Mix, TCH et al. (2005) Rationale - Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease. American Heart Journal, 149 . pp. 408-413. (doi:10.7016/j.ahj.2004.09.047)
Full text not currently available from Enlighten.
|Glasgow Author(s):||McMurray, Prof John|
|Authors:||Mix, TCH, Brenner, RM, Cooper, ME, de Zeeuw, D, Ivanovich, P, Levey, AS, McGill, JB, McMurray, JJV, Parfrey, PS, Parving, HH, Pereira, BJG, Remuzzi, G, Singh, AK, Solomon, SD, Stehman-Breen, C, Toto, RD, and Pfeffer, MA|
|College/School:||College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences|
College of Medical Veterinary and Life Sciences
|Journal Name:||American Heart Journal|